Tag: biosimilars
A deep dive into the Asian generic pharmaceutical landscape, comparing India's volume dominance with China's API control and the rise of emerging hubs.
Biosimilars aren't exact copies of biologics - tiny manufacturing differences can trigger immune responses. Learn why some patients develop antibodies, how administration and genetics affect risk, and what real-world data really shows.

Medications